News tagged with inspra
(HealthDay)—In the search for better medicines to safely help heart patients, clinical trials testing three new drugs appear to offer some promise.
Cardiology Mar 11, 2013 | 4 / 5 (1) | 0
The aldosterone antagonist eplerenone (Inspra, Pfizer) significantly reduced the development of new onset atrial fibrillation and flutter (AFF) in patients with class 2 heart failure, concludes a sub-analysis of the EMPHASIS-HF ...
Cardiology May 22, 2011 | 5 / 5 (1) | 0